“Bioquark has spent the last several years studying the natural ability of many species to turn back biological time in order to maintain health, fitness, and survival,” said Dr. Sergei Paylian, Founder, CSO, and President, Bioquark Inc.
Philadelphia, PA, and Karlovy Vary, Czech Republic (PRWEB) July 01, 2014
Bioquark, Inc., (http://www.bioquark.com) a company focused on the development of a novel biologic portfolio of products, services, and technologies for complex regeneration, disease reversion, and aging in humans, today announces the establishment of BioReprogen s.r.o (LLC) CZ operations at Alžbětiny Lázně, also known as Lazne 5 (http://www.alzbetinylazne.cz/en/) in Karlovy Vary, Czech Republic.
“We are excited about this next step in our progression as a full integrated company focused on a broad spectrum of regenerative healthcare products, services and technologies,” said Ira S. Pastor, CEO, Bioquark Inc. “The Lazne 5 facility provides an excellent location and environment to continue this part of our strategic business development.”
Originally established back in 1906 and named after the Empress Elizabeth (known as Sissi), the Lazne 5 facility continues a very successful and long spa tradition in the heart of Europe today. Currently offering a large range of traditional spa treatments, it also provides a modern selection of outpatient medical, rehabilitation, beauty, and wellness options.
“Bioquark has spent the last several years studying the natural ability of many species to turn back biological time in order to maintain health, fitness, and survival,” said Dr. Sergei Paylian, Founder, CSO, and President, Bioquark Inc. “The BioReprogen initiative is our next evolutionary step in allowing humans to recapture these capabilities to effectively counter our unfortunate progression into aging and degeneration.
About Bioquark, Inc.
Bioquark Inc. is focused on the development of natural biologic based products, services, and technologies, with the goal of curing a wide range of diseases, as well as effecting complex regeneration. Bioquark is developing both biological pharmaceutical candidates, as well as products for the global consumer health and wellness market segments.